For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Irx Therapeutics, Inc.

USPTO Granted Patents = 15

CIPO Patents = 3

EPO Patents = 6

Forward Citations = 90

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

John W Hadden (12 out of 17 patents)

James E Egan (8 out of 13 patents)

Harvey Brandwein (5 out of 7 patents)

4. Kathy L Signorelli (4 out of 4 patents)

5. Martin Kast (2 out of 2 patents)

6. Paul H Naylor (2 out of 2 patents)

7. Kathy L Signorelli-Petrat (2 out of 2 patents)

8. Theresa L Whiteside-Nimick (1 out of 1 patent)

9. George J Fennington, Jr (1 out of 2 patents)

10. Theresa L Whiteside (1 out of 1 patent)

11. Margareta Czystowska (1 out of 1 patent)

12. Paul Naylor (0 patent)

13. Paul Naylor (0 patent)

14. Harvey J Brandwein (0 patent)

15. George J Fennington (0 patent)

15 patents: Sort by Forward Citations

1. 9931378 - Method of immunotherapy for treatment of human papillomavirus infection (2018-04-03),

2. 9789173 - Vaccine immunotherapy for treating cervical cancer in immune suppressed patients (2017-10-17),

3. 9789172 - Vaccine immunotherapy for treating lymphoma in immune suppressed patients (2017-10-17),

4. 9566331 - Vaccine immunotherapy (2017-02-14),

5. 9539320 - Vaccine immunotherapy (2017-01-10),

6. 9492519 - Vaccine immunotherapy (2016-11-15),

7. 9492517 - Vaccine immunotherapy (2016-11-15),

8. 9333238 - Method of immunotherapy for treament of human papillomavirus infection (2016-05-10),

9. 8784796 - Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients (2014-07-22),

10. 8591956 - Method of increasing immunological effect (2013-11-26),

11. 8470562 - IRX-2 modified manufacturing process (2013-06-25),

12. 7993660 - Method of increasing immunological effect (2011-08-09),

13. 7182942 - Vaccine immunotherapy for immune suppressed patients (2007-02-27),

14. 7153499 - Vaccine immunotherapy for immune suppressed patients (2006-12-26),

15. 6977072 - Vaccine immunotherapy for immune suppressed patients (2005-12-20),

IRX Therapeutics, Inc. is a biopharmaceutical company specializing in the development of innovative immunotherapy treatments. With a focus on cancer research, IRX Therapeutics aims to harness the power of the immune system to effectively target and eliminate cancer cells. Their cutting-edge therapies have shown promising results in preclinical and clinical trials, offering hope for improved outcomes and quality of life for patients. Visit their website for more information on their groundbreaking research and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

15 Patents

#439 in New York, NY

#1,131 in New York

#20,409 in US

#38,696 in the World

New York, NY, United States of America

Irx Therapeutics, Inc.

Forward Citations = 90

11 inventors:

John W Hadden (12 out of 17 patents)

James E Egan (8 out of 13 patents)

Harvey Brandwein (5 out of 7 patents)

4. Kathy L Signorelli (4 out of 4 patents)

5. Martin Kast (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…